| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 461,375 | 398,327 | 409,023 | 698,901 | | Cost of Revenue | 511,548 | 447,760 | 485,980 | 652,612 | | | Gross Profit | (50,173) | (49,433) | (76,957) | 46,289 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,617 | 81,346 | 85,763 | 96,767 | | Non Recurring |
-
|
-
|
-
| 3,233 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (118,790) | (130,779) | (162,720) | (53,711) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,265 | 8,394 | 11,256 | 19,889 | | Earnings Before Interest And Taxes | (111,264) | (121,904) | (156,561) | (84,459) | | Interest Expense |
-
|
-
|
-
| 21,567 | | Income Before Tax | (111,264) | (121,904) | (156,561) | (106,026) | | Income Tax Expense | 361,067 | (38,739) | (67,666) | (27,205) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (472,331) | (83,165) | (88,895) | (78,821) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (472,331) | (83,165) | (88,895) | (78,821) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($472,331) | ($83,165) | ($88,895) | ($78,821) |
|
1.25% Nasdaq 
Income Statement
